Open access · CC-BY
via OpenAlex
The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations
Xuan Li, Ya Feng, Xi-Xi Wang, Daniel Truong, Yun‐Cheng Wu
Aging and Disease · 2020 · ▲ 134 citations
Epigenetic alterations
Deregulated nutrient-sensing
Mitochondrial dysfunction
Chronic inflammation
Disabled macroautophagy
Rapamycin / mTOR inhibition
Cell culture / in vitro
Human
In vitro
Abstract
Silence information regulator 1 (SIRT1), a member of the sirtuin family, targets histones and many non-histone proteins and participates in various physiological functions. The enzymatic activity of SIRT1 is decreased in patients with Parkinson's disease (PD), which may reduce their ability to resist neuronal damage caused by various neurotoxins. As far as we know, SIRT1 can induce autophagy(definition) by regulating autophagy related proteins such as AMP-activated protein kinase, light chain 3, mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), and forkhead transcription factor 1. Furthermore, SIRT1 can regulate mitochondrial function and inhibit oxidative stress mainly by maintaining peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) in a deacetylated state and thus maintaining a constant level of PGC-1α. Other studies have demonstrated that SIRT1 may play a role in the pathophysiology of PD by regulating neuroinflammation. SIRT1 deacetylases nuclear factor-kappa B and thus reduces its transcriptional activity, inhibits inducible nitric oxide synthase expression, and decreases tumor necrosis factor-alpha and interleukin-6 levels. SIRT1 can also upregulate heat shock protein 70 by deacetylating heat shock factor 1 to increase the degradation of α-synuclein oligomers. Few studies have focused on the relationship between SIRT1 single nucleotide polymorphisms and PD risk, so this topic requires further research. Based on the neuroprotective effects of SIRT1 on PD, many in vitro and in vivo experiments have demonstrated that some SIRT1 activators, notably resveratrol, have potential neuroprotective effects against dopaminergic neuronal damage caused by various neurotoxins. Thus, SIRT1 plays a critical role in PD development and might be a potential target for PD therapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.14336/ad.2020.0216
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Li, X., Feng, Y., Wang, X., Truong, D., & Wu, Y. (2020). The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations. <em>Aging and Disease</em>. https://doi.org/10.14336/ad.2020.0216
Vancouver
Li X, Feng Y, Wang X, Truong D, Wu Y. The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations. Aging and Disease. 2020. doi:10.14336/ad.2020.0216.
BibTeX
@article{xuan2020TheCri,
title = {The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations},
author = {Xuan Li and Ya Feng and Xi-Xi Wang and Daniel Truong and Yun‐Cheng Wu},
journal = {Aging and Disease},
year = {2020},
doi = {10.14336/ad.2020.0216},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Aging Neuroscience 2020
Open access · CC-BY
Emerging Role of Sirtuin 2 in Parkinson’s Disease
Oxidative Medicine and Cellular Longevity 2017
Open access · CC-BY
SIRT1 Activation by Resveratrol Alleviates Cardiac Dysfunction via Mitochondrial Regulation in Diabetic Cardiomyopathy Mice
Frontiers in Immunology 2022
Open access · CC-BY
Regulation of SIRT1 and Its Roles in Inflammation
International Journal of Alzheimer s Disease 2012
Open access · CC-BY
The Effects of SIRT1 on Alzheimer's Disease Models
Journal of Clinical Medicine 2020
Open access · CC-BY
Impact of Short-Term Hypoxia on Sirtuins as Regulatory Elements in HUVECs
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY